Company news
Aeon Biopharma, Inc. (AMEX:AEON) news
Every Aeon Biopharma, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
AEON Biopharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 12, 2026
AEON Biopharma Regains Compliance with NYSE American Continued Listing Standards
August 3, 2026
AEON Biopharma : Announces Pricing of Upsized $13.75 Million Public Offering with Accompanying Milestone Warrants Providing Potential for...
July 14, 2026
AEON Biopharma Announces Pricing of Upsized $13.75 Million Public Offering with Accompanying Milestone Warrants Providing Potential for A...
July 14, 2026
AEON Biopharma to Present Data Demonstrating Structural and Functional Comparability of ABP-450 to BOTOX® at the 68th Annual Scientific M...
June 4, 2026
AEON Biopharma Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 14, 2026
AEON Biopharma Sets Annual Shareholder Meeting
April 24, 2026
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
April 3, 2026
AEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing Standards
April 3, 2026
AEON Biopharma Reports Full Year 2025 Financial Results and Highlights Positive Comparative Analytical Results and FDA Feedback for ABP-4...
March 30, 2026
AEON Biopharma Announces FDA Feedback Following BPD Type 2a Meeting for the ABP-450 Biosimilar Program
March 25, 2026
AEON Biopharma Appoints John Bencich as Chief Financial Officer
March 9, 2026
AEON Biopharma Abstract Accepted for Presentation at 2026 American Academy of Neurology (AAN) Annual Meeting
March 5, 2026
AEON Biopharma Reports BPD Type 2a Meeting with FDA and Shareholder Approval of the November Transactions
January 21, 2026
AEON Biopharma Announces Execution of Exchange Agreement with Daewoong
December 15, 2025
AEON Biopharma Announces First Closing of PIPE Investment and Provides Update on FDA Type 2a Meeting Scheduling
November 20, 2025
AEON Biopharma Reports Third Quarter 2025 Results, Including Positive ABP-450 Biosimilarity Data and Strategic Positioning for Continued ...
November 14, 2025
AEON Biopharma Reports Positive and Robust Biosimilarity Results: Identical Amino Acid Sequence and Highly Similar Functional Analysis Data
November 13, 2025
AEON Biopharma Announces FDA BPD Type 2a Meeting for ABP-450 on November 19
October 1, 2025
AEON Biopharma Reports Second Quarter 2025 Financial Results and Provides Corporate Update
August 12, 2025
AEON Biopharma to Present at the Aegis Capital Corp. Virtual Conference 2025
May 19, 2025
AEON Biopharma Reports First Quarter 2025 Financial Results and Provides Corporate Update
May 14, 2025
AEON Biopharma : Reports Third Quarter 2024 Financial Results and Provides Corporate Update Form 8 K
November 13, 2024